Case Study What is the Relationship Between the Cell Membrane and Cystic Fibrosis?

Similar documents
A Case of Cystic Fibrosis

Respiratory Pharmacology: Treatment of Cystic Fibrosis

FACTS ABOUT. Cystic Fibrosis. What Is Cystic Fibrosis. What Are the Signs and Symptoms of CF?

Cystic Fibrosis. Information for Caregivers

Cystic Fibrosis. Parkland College. Monica Rahman Parkland College. Recommended Citation

Cystic Fibrosis Foundation Patient Registry 2013

The Cystic Fibrosis Gene. about. CF is one of the most common genetic diseases that cause death in both children and

Cystic Fibrosis. Na+ 2Cl - K+ Na+ Na+

Transformational Treatments. PRESTON W. CAMPBELL, III, M.D. Executive Vice President for Medical Affairs

THE ROLE OF CFTR MUTATIONS IN CAUSING CYSTIC FIBROSIS (CF)

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

What is the inheritance pattern (e.g., autosomal, sex-linked, dominant, recessive, etc.)?

Symdeko. Symdeko (tezacaftor and ivacaftor) Description

PULMONARY SURFACTANT, ALPHA 1 ANTITRYPSIN INHIBITOR DEFICIENCY, AND CYSTIC FIBROSIS DR. NABIL BASHIR BIOCHEMISTRY/RESPIRATORY SYSTEM

Orkambi. Orkambi (lumacaftor/ivacaftor) Description

Cystic Fibrosis. Presented by: Chris Belanger & Dylan Medd

Kalydeco. Kalydeco (ivacaftor) Description

A Guide for Understanding Genetics and Health

Friday, January 4. Bell Work:

Cost-effectiveness of Ivacaftor (Kalydeco ) for the treatment of cystic fibrosis in patients age 6 years and older who have the G551D mutation

Human Genetic Diseases (Ch. 15)

Cystic Fibrosis the future

CYSTIC FIBROSIS OBJECTIVES NO CONFLICT OF INTEREST TO DISCLOSE

What is Cystic Fibrosis? CYSTIC FIBROSIS. Genetics of CF

Human Genetic Diseases. AP Biology

Cystic Fibrosis in Canada

"Management and Treatment of Patients with Cystic fibrosis (CF)

Lesson Overview. Human Genetic Disorders. Lesson Overview Human Genetic Disorders

Human Genetic Disorders. Lesson Overview. Lesson Overview Human Genetic Disorders

THE ROLE OF CFTR MUTATIONS IN CAUSING CYSTIC FIBROSIS (CF)

UNDERSTANDING CYSTIC FIBROSIS

Lesson Overview. Human Genetic Disorders. Lesson Overview Human Genetic Disorders

Exemplar for Internal Achievement Standard. Biology Level 3

Cystic Fibrosis New Patient Binder Cystic Fibrosis Center Pediatric Pulmonary Division

Human Genetic Diseases. AP Biology

PomPom SHOOTER. Activity Background: Common Obstructive Lung Disorders:

Diseases of the gastrointestinal system. H Awad Lecture 2: small intestine/ part 2 and appendix

E-BOOK # PANCREATIC ENZYMES FOR CYSTIC FIBROSIS ARCHIVE


Pediatrics Grand Rounds 18 Sept University of Texas Health Science Center. + Disclosure. + Learning Objectives.

Movement across the Membrane

The Role of the Cell Membrane in Transport

Genetic Disease, Genetic Testing and the Clinician

Function of the skeleton

Enabling CF Therapeutic Development

Transport through biological membranes. Christine Carrington Biochemistry Unit Apr 2010

B1 Question 1 Foundation

Chapter 8. Movement across the Cell Membrane. diffusion. Diffusion of 2 solutes. Cell (plasma) membrane. Diffusion 9/7/2012

Figure 1: Transmission of Wing Shape & Body Color Alleles: F0 Mating. Figure 1.1: Transmission of Wing Shape & Body Color Alleles: Expected F1 Outcome

Chapter 4: Cells and Their Environment

Cystic Fibrosis Carrier Testing

Chapter 7. Movement across the Cell Membrane

Cystic Fibrosis. Jennifer McDaniel, BS, RRT-NPS

PREDICTING INHERITED TRAITS & PUNNETT SQUARE ANALYSIS

Genome - Wide Linkage Mapping

Treacher-Collins Syndrome by Nicholas Amendolare

Diffusion. Chapter 7. Movement across the Cell Membrane. Cell (plasma) membrane. diffusion. Building a membrane. Diffusion of 2 solutes

Patterns of Inheritance

2 kinds of secondary active transport Ion and solute move in the same direction = symport Example: Na + and glucose in the kidney 2 kinds of secondary

Briefing Document. FDA Pulmonary - Allergy Drugs Advisory Committee

Cell Membrane and Transport

TRANSPORT ACROSS MEMBRANES

B1 Revision You and Your Genes. You and Your Genes (B1) Revision for Exam

Genetic Carrier Testing Cystic Fibrosis (CF) Spinal Muscular Atrophy (SMA) Fragile X Syndrome

Pharmacogenomics in Rare Diseases: Development Strategy for Ivacaftor as a Therapy for Cystic Fibrosis

A Genetic Approach to the Treatment of Cystic Fibrosis

PATIENT EDUCATION. Cystic Fibrosis Carrier Testing

The Future of CF Therapy

Excretion and Water Balance

Tay Sachs, Cystic Fibrosis, Sickle Cell Anemia and PKU. Tay Sachs Disease (also called Hexosaminidase deficiency)

Pediatrics Grand Rounds 13 November University of Texas Health Science Center at San Antonio. Learning Objectives

The Deciphering Development Disorders (DDD) project: What a genomic approach can achieve

Chapter 4 Cell Membrane Transport

A Guide for Understanding Genetics and Health

Diffusion across cell membrane

What You ll Learn. Genetics Since Mendel. ! Explain how traits are inherited by incomplete dominance

Pass the salt please!

Why every baby should be protected from pertussis (whooping cough)

Clinical Commissioning Policy: Levofloxacin nebuliser solution for chronic Pseudomonas lung infection in cystic fibrosis (all ages)

Evaluation of Patients with Diffuse Bronchiectasis

Oral Cystic Fibrosis Modulators

Tracking Genetic-Based Treatment Options for Inflammatory Bowel Disease

Pulmo-Park Pom-Pom Shooter: Measuring the Effect of Restricted Breathing on Peak Expiratory Flow (PEF) Student Information Page Activity 5D

Clinical Commissioning Policy: Ivacaftor for Cystic Fibrosis (named mutations)

Digestive System 7/15/2015. Outline Digestive System. Digestive System

A Guide for Understanding Genetics and Health

3- Cell Structure and Function How do things move in and out of cells? A Quick Review Taft College Human Physiology

Lecture 3 (Oct 5 th ): NEURONS AND NERVE IMPULSES Lecture Outline

Transport across the cell membrane

Unit 1 Matter & Energy for Life

2015 AP Biology Unit #4 Test Cell Communication, Cancer, Heredity and The Cell Cycle Week of 30 November

The Phospholipids Between Us (Part 2) Transport through Cell Membranes

Changes in the management of children with Cystic Fibrosis. Caroline Murphy & Deirdre O Donovan CF Nurses

What kind of things must pass into and out of cells?? Be careful not to go too fast.

Disclosures. Advances in the Management of Cystic Fibrosis: A Closer Look at the Roles of CFTR Modulation Therapy 10/28/2016

UNIT 3 Conditions supporting life

1. The barriers of the innate immune system to infection

Supplementary appendix

Cell Membranes and Signaling

Transcription:

Names: Date: Case Study What is the Relationship Between the Cell Membrane and Cystic Fibrosis? Dr. Weyland examined a six month old infant that had been admitted to University Hospital earlier in the day. The baby's parents had brought young Zoey to the emergency room because she had been suffering from a chronic cough. In addition, they said that Zoey sometimes would "wheeze" a lot more than they thought was normal for a child with a cold. Upon arriving at the emergency room, the attending pediatrician noted that salt crystals were present on Zoey's skin and called Dr. Weyland, a pediatric pulmonologist. Dr. Weyland suspects that baby Zoey may be suffering from cystic fibrosis. CF affects more than 30,000 kids and young adults in the United States. It disrupts the normal function of epithelial cells cells that make up the sweat glands in the skin and that also line passageways inside the lungs, pancreas, and digestive and reproductive systems. The inherited CF gene directs the body's epithelial cells to produce a defective form of a protein called CFTR (or cystic fibrosis transmembrane conductance regulator) found in cells that line the lungs, digestive tract, sweat glands, and genitourinary system. When the CFTR protein is defective, epithelial cells can't regulate the way that chloride ions pass across cell membranes. This disrupts the balance of salt and water needed to maintain a normal thin coating of mucus inside the lungs and other passageways. The mucus becomes thick, sticky, and hard to move, and can result in infections from bacterial colonization. 1. "Woe to that child which when kissed on the forehead tastes salty. He is bewitched and soon will die" This is an old saying from the eighteenth century and describes one of the symptoms of CF (salty skin). Why do you think babies in the modern age have a better chance of survival than babies in the 18th century? 2. What symptoms lead Dr. Weyland to his initial diagnosis? 3. Consider the graph of infections, which organism stays relatively constant in numbers over a lifetime? What organism is most likely affecting baby Zoey? 4. Explain how the CF gene affects the cell membrane.

Part II: CF is a disorder of the cell membrane. Imagine a door with key and combination locks on both sides, back and front. Now imagine trying to unlock that door blind folded. This is the challenge faced by David Gadsby, Ph.D., who for years struggled to understand the highly intricate and unusual cystic fibrosis chloride channel a cellular doorway for salt ions that is defective in people with cystic fibrosis. His findings, reported in a series of three recent papers in the Journal of General Physiology, detail the type and order of molecular events required to open and close the gates of the cystic fibrosis chloride channel, or as scientists call it, the cystic fibrosis transmembrane conductance regulator (CFTR). Ultimately, the research may have medical applications, though ironically not likely for most cystic fibrosis patients. Because two thirds of cystic fibrosis patients fail to produce the cystic fibrosis channel altogether, a cure for most is expected to result from research focused on replacing the lost channel. 5. Compare the normal and the mutant CFTR protein. How would you correct the mutant protein if you had the ability to tinker with it on a molecular level? 6. Why would treatment that targets the CFTR channel not be effective for ⅔ of those with cystic fibrosis? 7. Sweat glands cool the body by releasing perspiration (sweat) from the lower layers of the skin onto the surface. Sodium and chloride (salt) help carry water to the skin's surface and are then reabsorbed into the body. Why does a person with cystic fibrosis have salty tasting skin? Part III: No cell is an island Like people, cells need to communicate and interact with their environment to survive. One way they go about this is through pores in their outer membranes, called ion channels, which provide charged ions, such as chloride or potassium, with their own personalized cellular doorways. But, ion channels are not like open doors; instead, they are more like gateways with high security locks that are opened and closed to carefully control the passage of their respective ions. In the case of CFTR, chloride ions travel in and out of the cell through the channel s guarded pore as a means to control the flow of water in and out of cells. In cystic fibrosis patients, this delicate salt/water balance is disturbed, most prominently in the lungs, resulting in thick coats of mucus that eventually spur life threatening infections. Shown below are several mutations linked to CFTR:

Mutation Class I Class II Class III Class IV Class V Description Gene contains a stop signal that prevents CFTR from being made. CFTR is made, but does not reach the cell membrane CFTR is made and in the right place, but does not function normally Channel does not move substances efficiently or at all CFTR is made in smaller than normal quantities 8. Which mutation do you think would be easiest to correct? Justify your answer. 9. Consider what you know about proteins, why does the "folding" of the protein matter? Part IV: Open Sesame Among the numerous ion channels in cell membranes, there are two principal types: voltage gated and ligand gated. Voltage gated channels are triggered to open and shut their doors by changes in the electric potential difference across the membrane. Ligand gated channels, in contrast, require a special key to unlock their doors, which usually comes in the form of a small molecule. CFTR is a ligand gated channel, but it s an unusual one. Its key is ATP, a small molecule that plays a critical role in the storage and release of energy within cells in the body. In addition to binding the ATP, the CFTR channel must snip a phosphate group one of three P s off the ATP molecule to function. But when, where and how often this crucial event takes place has remained obscure. 10. Compare the action of the ligand gated channel to how an enzyme works. Consider the model of the membrane channel, what could go wrong to prevent the channel from opening?

12. Where is ATP generated in the cell? How might ATP production affect the symptoms of cystic fibrosis? 13. Label the image to the right to show how the ligand gated channel for CFTR works. Include a summary or how this channel works. Part V: Can a Drug Treat Zoey's Condition? Dr. Weyland confirmed that Zoey does have cystic fibrosis and called the parents in to talk about potential treatments. Good news, there are two experimental drugs that have shown promise in CF patients. These drugs can help Zoey clear the mucus from her lungs. Unfortunately, the drugs do not work in all cases. The doctor gave the parents literature about the drugs and asked them to consider signing Zoey up for trials. The Experimental Drugs Ivacaftor is a potentiator that increases CFTR channel opening time. We know from the cell culture studies that this increases chloride transport by as much as 50% from baseline and restores it closer to what we would expect to observe in wild type CFTR. Basically, the drug increases CFTR activity by unlocking the gate that allows for the normal flow of salt and fluids. In early trials, 144 patients all of whom were age over the age of 12 were treated with 150 mg of Ivacaftor twice daily. The total length of treatment was 48 weeks. Graph A shows changes in FEV (forced expiratory volume) with individuals using the drug versus a placebo. Graph B shows concentrations of chloride in patient s sweat. 14. What is FEV (if you're not sure, look this one up)? Describe a way that a doctor could take a measurement of FEV. 15. Why do you think it was important to have placebos in both of these studies? 16. Which graph do you think provides the most compelling evidence for the effectiveness of Ivacaftor. Defend your choice. 17. Take a look at the mutations that can occur in the cell membrane protein from Part III. For which mutation do you think Ivacaftor will be most effective. Justify your answer.

18. Would you sign Zoey up for clinical trials based on the evidence? What concerns would a parent have before considering an experimental drug? Part VI: Zoey's Mutation Dr. Weyland calls a week later to inform the parents that genetic tests show that Zoey chromosomes show that she has two copies of the F508del mutation. This mutation, while the most common type of CF mutation, is also one that is difficult to treat with just Ivacaftor. There are still some options for treatment. Lumacaftor In people with the most common CF mutation, F508del, a series of problems prevents the CFTR protein from taking its correct shape and reaching its proper place on the cell surface. The cell recognizes the protein as not normal and targets it for degradation before it makes it to the cell surface. In order to treat this problem, we need to do two things: first, an agent to get the protein to the surface, and then ivacaftor (VX 770) to open up the channel and increase chloride transport. VX 809 has been identified as a way to help with the trafficking of the protein to the cell surface. When added VX 809 is added to ivacaftor (now called Lumacaftor,) the protein gets to the surface and also increases in chloride transport by increasing channel opening time. In early trials, experiments were done in vitro, where studies were done on cell cultures to see if the drugs would affect the proteins made by the cell. General observations can be made from the cells, but drugs may not work on an individual s phenotype. A new type of research uses ex vivo experiments, where rectal organoids (mini guts) were grown from rectal biopsies of the patient that would be treated with the drug. Ex vivo experiments are personalized medicine, each person may have different correctors and potentiators evaluated using their own rectal organoids. The graph below shows how each drug works for 8 different patients (#1 #8). Swelling in the organoid indicates the the channels within the cell membrane are allowing material to pass. 19. One the graph, label the group that represents Ivacaftor and Lumacaftor. What is the difference between these two drugs? 20. How does VX 809 work? For which mutation type would VX 809 be most effective? 21. If the profile labeled #4 is Zoey, rank the possible drug treatments in order of their effectiveness for her mutation. 22. Compare ex vivo trials to in vitro trials. 23. Consider the mutations in Part III again. Which mutation do you think will be the hardest to develop treatments for. Justify your answer.